PPB Approval

XELJANZ ORAL SOLUTION 1MG/ML

Registration Code

HK-68192

Sale Requirement

Prescription only Medicines

Registration Date

April 8, 2024

Company NamePfizer Corporation Hong Kong Limited

Company Information

Company Details

Company NamePfizer Corporation Hong Kong Limited

Company Address

21/F, KERRY CENTRE, 683, KING'S ROAD, QUARRY BAY, HONG KONG

Active Ingredients

Ingredient Name

tofacitinib (as citrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

XELJANZ ORAL SOLUTION 1MG/ML - PPB 批准文号 | MedPath